Va. Starnes et al., LOBAR TRANSPLANTATION - INDICATIONS, TECHNIQUE, AND OUTCOME, Journal of thoracic and cardiovascular surgery, 108(3), 1994, pp. 403-411
Lobar transplantation represents a therapeutic option for children and
some adults with severe endstage pulmonary disease. Six patients incl
uding two neonates, three children, and one adult underwent lobar tran
splantation. Ages ranged from 17 days to 21 years. Transplant procedur
es were unilateral in the neonates and two of the children and bilater
al in the child and adult who had cystic fibrosis. The donor lobes wer
e from cadavers in the two neonates and living related donors in the c
hildren and the adult. Unilateral grafts involved use of the right upp
er lobe in the 12-year-old patient with bronchopulmonary dysplasia; ri
ght middle lobe with a ventricular septal defect repair in the 4-year-
old patient with Eisenmenger's syndrome, left upper lobe in the 28-day
-old patient with primary pulmonary hypertension, and the right upper
and middle lobes in the 17-day-old patient with diaphragmatic hernia.
Bilateral lobar transplantations were performed with the right lower a
nd left lower lobes in the two patients with cystic fibrosis (aged 13
and 21 years). The two neonates underwent emergency transplantation wi
th the use of extracorporeal membrane oxygenation as a bridge. Periope
rative survival was 83 %, with only the 4-year-old patient with ventri
cular septal defect/Eisenmenger's syndrome dying early. No airway comp
lications were observed. The unilateral grafts received most of the bl
ood flow as shown by perfusion scanning (range 74% to 99%). Living rel
ated donor complications included prolonged air leaks (>6 days) in two
patients. In urgent situations, such as an infant requiring extracorp
oreal membrane oxygenation, and in the existing milieu of donor shorta
ge, lobar transplantation Giving related or cadaveric) is a surgically
feasible procedure and can provide a donor source in the limited time
frame of these clinical situations. Bilateral lobe transplantation ma
y be a viable option for patients with cystic fibrosis and life-threat
ening respiratory decompensation.